| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,150 | 03 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123007541-bracken-racquel-2023-02-03 | Cyteir Therapeutics, Inc. | 03 Feb 2023 | 1 | $0 | 4 | Director | 07 Feb 2023, 15:42 |
| /report/000089924322007646-bracken-racquel-2022-02-22 | Cyteir Therapeutics, Inc. | 22 Feb 2022 | 1 | $0 | 4 | Director | 24 Feb 2022, 15:59 |
| /report/000089924321024589-bracken-racquel-2021-06-17 | Cyteir Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Director | 17 Jun 2021, 21:34 |